General Anesthesia Management in 15 Preterm Infant
NCT03044366 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2017-02-09
Summary
Anesthesia management of preterm infants is challenging for the anesthesiologist. Because of rudimentary build, many medical and physical problems have shown in treatment of disease such as complications, airway problems, temperature disregulation and deficient drug metabolism. This retrospective study evaluates the perioperative management and postoperative course in premature infants undergoing diode laser photocoagulation (DLP) for retinopathy of prematurity (ROP).
Conditions
- Anesthesia Management of Premature Infants
Interventions
- OTHER
-
general anesthesia management of preterm infants
general anesthesia management of preterm infants
Sponsors & Collaborators
-
Inonu University
lead OTHER
Eligibility
- Max Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
NCT02050971 ·Status: UNKNOWN ·Phase: PHASE1
-
Near-Infrared Spectroscopy and Cranial Doppler in Premature Newborns With Anemia
NCT04509375 ·Status: UNKNOWN
-
Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy
NCT01550627 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
NCT05880433 ·Status: COMPLETED
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
NCT05806684 ·Status: UNKNOWN
-
Effect of Erythropoietin on Preterm Brain Injury
NCT02036073 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
NCT01203514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Transfusion of Prematures Trial
NCT01702805 ·Status: COMPLETED ·Phase: NA
-
The Effects of Minimal Enteral Nutrition on Mesenteric Blood Flow and Oxygenation in Neonates With HIE
NCT06344286 ·Status: COMPLETED ·Phase: NA
-
Measurement of Cerebral and Peripheric Tissue Oxygenation in Anemic Preterm Infants Who Underwent Blood Transfusion
NCT01251068 ·Status: UNKNOWN ·Phase: NA
-
Iron Metabolism in Small Pre Term Newborns
NCT01443195 ·Status: UNKNOWN ·Phase: NA
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
NCT03919500 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Function in Sick and Healthy Preterm Infants Admitted in NICU of Assiut University Children Hospital
NCT05632965 ·Status: UNKNOWN
-
Blood Transfusions in Preterm Infants
NCT05331235 ·Status: UNKNOWN
-
Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula
NCT05735964 ·Status: RECRUITING ·Phase: NA
-
Does Erythropoietin Improve Outcome in Very Preterm Infants?
NCT00413946 ·Status: COMPLETED ·Phase: PHASE2
-
Neonatal Erythropoietin in Asphyxiated Term Newborns
NCT00719407 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Enteral Feeding on Splanchnic Oxygenation During Packed Red Blood Cell Transfusion in Preterm Infants
NCT06632314 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
NCT05853601 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease
NCT02395783 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
NCT01079715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
NCT04584983 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2